GROWMARK plans new agricultural biologicals plant in St. Louis

GROWMARK has announced plans to build a new agricultural biologicals manufacturing facility in St. Louis, Missouri, expanding its footprint in a fast-growing segment of crop inputs. The plant will be located at the company’s AgraForm site, which already produces and packages insecticides, fungicides, and biological products.

The investment comes as demand for biological crop inputs outpaces existing manufacturing capacity, creating bottlenecks for agricultural companies seeking domestic production options. The facility is expected to begin operations in early 2027.

What happened?

• GROWMARK said it will construct a state-of-the-art biological crop input manufacturing plant at its St. Louis AgraForm site.
• The company acquired AgraForm in 2024.
• The new plant will manufacture biological crop inputs for agricultural companies lacking in-house production or seeking additional capacity.
• The facility will also be capable of producing animal biological and waste treatment products.
• Planned outputs include biostimulants, biopesticides, and biofertilizers.

Company saying

“The scientific advancements in agricultural biologicals have introduced innovative methods for farmers to safeguard their plants and improve soil health with more sustainable options,” said Rod Wells, GROWMARK’s senior vice president of strategy and logistics. “It’s beneficial for both farmers and consumers when we enable farmers to grow healthier and stronger crops using these sustainable practices.”

“As demand for biological products continues to grow across the ag industry, the construction of the new manufacturing plant will allow GROWMARK to provide high-quality biological products, made in the United States, to stakeholders throughout North America,” said Brad Drake, executive vice president and chief operating officer. “It also allows GROWMARK to influence another critical point in the ag value chain to better serve its members and customers.”

Why is this important?

• Global demand for agricultural biologicals is growing faster than current manufacturing capacity.
• Additional U.S.-based production could reduce supply constraints for biological crop inputs.
• Biological products are increasingly used alongside or instead of synthetic inputs to support soil health, pest control, and nutrient efficiency.
• The project strengthens GROWMARK’s role in the agricultural value chain and expands options for its members and customers.